Skip to content Skip to footer

Post-Conference Highlights | 2026 ViVE | Feb 22–25 | Los Angeles, CA

ViVE 2026 in Los Angeles convened policymakers, health system executives, payers, technologists, investors, and founders at a pivotal moment for healthcare. Across three days, discussions moved decisively from digital ambition to operational accountability. As the official Media Partner, PharmaShots presents a comprehensive review of the sessions, speakers, and strategic insights that defined ViVE 2026. Day…

Read more

Evolution Summit By Marcus Evans | May 7-8, 2026 | The Ritz-Carlton, Fort Lauderdale, Florida

The Evolution Summit returns May 7-8, 2026 at The Ritz-Carlton, Fort Lauderdale, Florida, bringing together leading clinical trial executives with innovative suppliers and solution providers in an invitation-only, premium setting.  Expect visionary keynotes, real-world case studies, and interactive forums aligned to the most pressing challenges in clinical operations and drug development. Featured leaders include…

Read more

A New Era in Neuropsychiatry: Dr. Velichka Valcheva on GH Research’s Rapid-Acting Breakthrough, GH001

Shots:   GH001, an inhaled formulation of mebufotenin, is emerging as a highly differentiated therapy for treatment-resistant depression, delivering ultra-rapid and profound symptom improvement – patients come to the clinic depressed and many leave in remission already on the same day. Long term, in a Phase 2b trial, 73% of patients who completed six months were in remission—substantially higher than the…

Read more

Transforming Lupus Management: Caterina Brindicci Shares AstraZeneca’s Approach to Patient-Focused Care 

Shots:  TULIP-SC full results reinforce efficacy and remission potential with subcutaneous Saphnelo, showing higher disease activity reduction (56.2% vs 34% placebo at Week 52), improved BICLA response, DORIS-defined remission, and reduced oral corticosteroid use, consistent with the IV formulation  Self-administration expands access and adherence, offering flexible at-home or clinic dosing, supporting earlier biologic intervention and steroid…

Read more

Next Pharma Summit 2026 | May 19-20, Dubrovnik

Next Pharma Summit is a 2-day, multi-stage conference for pharma professionals passionate about Digital, Commercial, Medical Affairs, AI, Technology, and beyond. As pharma rapidly redefines its purpose, NEXT brings together cross-functional leaders to foster smarter collaboration and create meaningful impact for customers, HCPs, and patients. One simple question guides us: Where to NEXT? Use…

Read more

Powering the Next Era of Animal Health: Gary Yang on CPBIO’s Global Strategy 

Shots:  CPBIO’s expanding global footprint is powered by a science-led strategy that connects innovation, partnerships, and emerging market growth with a core goal: turning evidence-based R&D into practical solutions that improve livestock productivity, resilience, and sustainability.  The company delivers species-specific solutions across poultry, swine, ruminants, and aquaculture while following a unified R&D philosophy focused on…

Read more

Reimagining Care Beyond Clinical Walls | Dr. Aasim Saeed | ViVE 2026 Pre-Conference Interview

Shots: In the PharmaShots ViVE Pre-Conference Interview Series, Dr. Aasim Saeed, Founder & CEO of Amenities Health, reveals how healthcare is moving beyond hospital walls, blending clinical care with social and non-medical support to unlock better, more human-centered patient outcomes He explores the power of digitally enabled, whole-person care models that connect health systems with…

Read more

Pharma & Biotech Quality Summit 2026 | May 12-13 | Leonardo Hotel Munich Arabellapark, Germany

The Pharma & Biotech Quality Summit 2026 brings together senior quality leaders to address the evolving challenges of quality management in a rapidly changing regulatory and technological landscape. Taking place in Munich on 12–13 May 2026, the summit focuses on how quality functions are adapting to AI-driven systems, advanced therapies, accelerated development timelines, and increasing…

Read more

Bringing Lupus Care Closer to Patients: Caterina Brindicci on AstraZeneca’s Next Chapter in Immunology

Shots:  AstraZeneca’s patient-focused immunology vision is reinforced by the EU approval of subcutaneous, self-administered Saphnelo (anifrolimab), offering people with SLE a more convenient option that reduces treatment burden, supports earlier biologic use, and advances the goal of remission beyond symptom control  The new formulation is expected to improve access, uptake, and adherence while easing infusion capacity constraints, with regulatory…

Read more